Skip to main content
. 2020 Oct 23;15(4):2126–2138. doi: 10.1007/s11682-020-00408-1

Table 1.

Demographic, clinical, and neuropsychological measures of patients and healthy controls; data are shown as mean (standard deviation) or count (percentage)

Variable ALS patients
(n = 32)
HCs
(n = 21)
t-test/χ2 p-value Below\above cut-off scorea
Demographics:
 Age, years 58.3 (10.3) 56.0 (10.1) − 0.8 0.40 -
 Education, years 10.5 (4.3) 12.5 (3.04) 1.8 0.10 -
 Sex, male 25 (78%) 15 (71%) 0.3 0.60 -
Clinical features:
 Symptom duration, months 19.5 (24.6) - - - -
 ALSFRS-R total score 39.0 (6.8) - - - -
 Bulbar subscore 10.7 (2.2) - - - -
 Fine motor subscore 8.5 (3.0) - - - -
 Gross motor subscore 8.6 (2.9) - - - -
 Respiratory subscore 11.1 (1.9) - - - -
 Disease Progression Rate* 0.8 (0.7) - - - -
 Upper Motor Neuron score 7.1 (5.0) - - - -
Neuropsychological measures:
 Global cognition:
 Mini Mental State Examination 28.3 (1.6) 28.5 (1.1) 0.5 0.60 0
 ECAS total score 90.9 (21.3) 100.6 (9.0) 1.9 0.10 4
 ECAS subscores:
 Executive functions 29.18 (9.75) 34.29 (5.35) 2.1 0.03 17
 Fluency 16.22 (7.26) 17.67 (4.64) 0.7 0.43 11
 Language 21.68 (4.04) 22.05 (2.69) 0.3 0.71 12
 Memory 13.04 (5.35) 15.86 (3.21) 2.1 0.03 7
 Visuospatial abilities 10.7 (1.6) 10.7 (1.3) 0.1 0.91 5
 Executive functions:
 Letter fluency task 26.9 (11.8) - - - 5
 Semantic fluency task 20.1 (6.0) - - - 1
 SF Index** 29.2 (13.4) - - - -
 PF Index** 9.0 (11.3) - - - -
 Stroop test – seconds 24.6 (10.0) - - - 3
 Stroop test – number of errors 1.0 (2.5) - - - 1
 Memory:
 RAVLT-immediate recall 38.5 (9.0) - - - 3
 RAVLT-delayed recall 8.2 (2.4) - - - 3
 Digit Span forward 5.1 (0.9) - - - 1
 Digit Span backward 3.2 (0.8) - - - 9
 Corsi Block-Tapping test 4.8 (0.7) - - - 0
 Non verbal Intelligence:
 Coloured Progressive Matrices 26.3 (4.9) - - - 0
Behavioural assessment:
 ALS-FTD Q (cut-off ≥ 22) 13.1 (9.7) - - - 4
 Hamilton HDRS 10.0 (4.2) - - - 2

Note. ALS, Amyotrophic Lateral Sclerosis; ALSFRS-R, ALS Functional Rating Scale Revised; ALS-FTD-Q, ALS-Frontotemporal Dementia questionnaire; ECAS, Edinburgh Cognitive and Behavioural ALS Screen; HCs, Healthy Controls; PF, Phonemic fluency; RAVLT, Rey’s Auditory Verbal Learning Test; SF, Semantic fluency; χ2, Chi-square test. *Disease Progression Rate was computed as: 48 – ALSFRS-R/Disease Duration. **Verbal fluency indices were obtained as following: time for generation condition - time for control condition (reading or writing generated words)/total number of items generated; a number of patients with cognitive performance\behavioural symptoms below\above cut-off score